Patents Assigned to University
  • Patent number: 7604804
    Abstract: The present invention relates to multivalent HIV inhibitors that bind to multiple sites on a trimeric gp120 complex thereby blocking the CD4 binding site on the trimeric gp120 complex and inhibiting the attachment and entry of HIV through gp120-CD4 interactions.
    Type: Grant
    Filed: February 9, 2005
    Date of Patent: October 20, 2009
    Assignee: University of Maryland Biotechnology Institute
    Inventors: Lai-Xi Wang, Hengguang Li
  • Patent number: 7605529
    Abstract: A field emission device includes a transparent anode substrate, an anode, a cathode substrate, a cathode, and a fluorescent layer. The anode is formed on the anode substrate. The cathode is formed on the cathode substrate. The cathode faces toward the anode and is spaced therefrom at a predetermined distance. The fluorescent layer is formed on the cathode and faces toward the anode. A method for manufacturing the field emission device is also disclosed.
    Type: Grant
    Filed: October 30, 2006
    Date of Patent: October 20, 2009
    Assignees: Tsinghua University, Hon Hai Precision Industry Co., Ltd.
    Inventors: Yuan Yao, Jie Tang, Shou-Shan Fan
  • Patent number: 7604973
    Abstract: The present invention relates to a nucleic acid segment having a coding region segment encoding enzymatically active Pasteurella multocida hyaluronate synthase (PmHAS), and to the use of this nucleic acid segment in the preparation of recombinant cells which produce hyaluronate synthase and its hyaluronic acid product.
    Type: Grant
    Filed: May 1, 2007
    Date of Patent: October 20, 2009
    Assignee: The Board of Regents of the University of Oklahoma
    Inventor: Paul DeAngelis
  • Patent number: 7604746
    Abstract: The present application discloses a composite membrane comprising (a) a support member that has a plurality of pores extending through the support member and (b) a cross-linked copolymer comprising (i) a cationic monomer and an anionic monomer and/or (ii) a zwitterionic monomer, which cross-linked copolymer fills the pores of the support member, the cross-linked copolymer having a permeability for a fluid that is dependent on the polarity of the fluid, wherein the permeability increases with increasing polarity. The present application also discloses a process for the preparation of the composite membrane, a pervaporation apparatus comprising the composite membrane, and methods for the use of the composite material in separation and dehydration processes.
    Type: Grant
    Filed: April 25, 2005
    Date of Patent: October 20, 2009
    Assignee: McMaster University
    Inventors: Ronald F. Childs, Jie Yu
  • Patent number: 7605897
    Abstract: Methods, systems and apparatus for a liquid crystal display panel having a first substrate with a color filter, an over-coating and a common electrode. The second substrate includes an insulating layer surface facing the first substrate, a pixel electrode, a plurality of common and pixel domain guides formed on the common and the pixel electrodes, a plurality of electric shields on one of the common or pixel electrodes and a liquid crystal layer vertically aligned between the first and second substrates. The panel also includes a drive circuit for applying a voltage to generate an electric field to control liquid crystal molecule orientation corresponding to the plurality of domain guides and electric shields to form a multi-domain liquid crystal display panel device. The plural domain guides are either protrusions or slits formed in the common electrode and the pixel electrode to form the multi-domain vertical alignment liquid crystal device.
    Type: Grant
    Filed: July 20, 2007
    Date of Patent: October 20, 2009
    Assignees: University of Central Florida Research Foundation Inc., Chi Mei Optoelectronics, Corp.
    Inventors: Ruibo Lu, Seung Hee Lee, Shin-Tson Wu, Wang-Yang Li, Chung-Kuang Wei
  • Patent number: 7606612
    Abstract: A system and method to perform parallel MR imaging are disclosed. The system comprises an MR imaging machine and a probe having at least two MR RF reception coils. Each coil of the probe is operationally connected to a separate receiver channel of the MR imaging machine. The MR imaging machine implements a partially parallel acquisition method to excite precessing nuclear spins, in and around an internal segment of a patient into which the probe is inserted, and to use the coils of the catheter to simultaneously sample a plurality of response signals to form reduced k-space data sets for each of the coils. The plurality of response signals represent nuclear magnetic resonance signals arising from the precessing nuclear spins. The reduced k-space data sets are further processed by the MR imaging machine to generate a full volume dataset of a region in and around the vessel.
    Type: Grant
    Filed: May 19, 2005
    Date of Patent: October 20, 2009
    Assignee: Case Western Reserve University
    Inventors: Claudia M. Hillenbrand, Mark A. Griswold, Eddy Wong, Jeffrey Duerk
  • Patent number: 7604953
    Abstract: A process of detection of the causative agent of Johne's disease (Mycobacterium avium subsp. paratuberculosis) (MAP) by detecting shedding of surface protein of MAP. A preferred way is use of surface enhanced Raman Spectroscopy. The system of detecting MAP shedding of protein provides early detection and diagnosis, and therefore allows early treatment for Johne's disease in ruminant animals.
    Type: Grant
    Filed: May 30, 2008
    Date of Patent: October 20, 2009
    Assignees: Iowa State University Research Foundation, Inc., The United States of America as represented by the Department of Agriculture/Cooperative State Research Education and Extension Service (USDA/CSREES)
    Inventors: Marc D. Porter, Betsy Jean Yakes, Robert J. Lipert, John P. Bannantine
  • Patent number: 7605385
    Abstract: An electrode-less discharge source of extreme ultraviolet (EUV) radiation (10) efficiently assembles a hot, dense, uniform, axially stable plasma column (5) with magnetic pressure and inductive current drive. It employs theta-pinch-type magnetic compression of plasma confined in a magnetic mirror. Plasma, confined in a magnetic mirror, is made to radiate by resonant magnetic compression. The device comprises a radiation-source gas input nozzle (1), an optional buffer-gas input flow (2), mirror-field coils (9a, 9b), theta-pinch coils (8a, 8b), a plasma and debris dump (11), and an evacuation port (7). The circular currents yield an axially stable plasma-magnetic-field geometry, and a reproducible, stable, highly symmetrical EUV source.
    Type: Grant
    Filed: July 28, 2005
    Date of Patent: October 20, 2009
    Assignee: Board of Regents of the University and Community College System of Nevada, on behlaf of the University of Nevada
    Inventor: Bruno Bauer
  • Patent number: 7605288
    Abstract: Novel compounds useful for inhibiting the 90 kDa heat shock proteins containing a quinone-like moiety and a di-hydroxy phenol like moiety, similar to geldanamycin and radicicol.
    Type: Grant
    Filed: March 26, 2007
    Date of Patent: October 20, 2009
    Assignee: University of Kansas
    Inventors: Brian Blagg, Gang Shen, Randell C. Clevenger
  • Patent number: 7605142
    Abstract: A method of treating a tumor (in particular osteosarcoma or Ewing's sarcoma) in a host by administering to a host or to the tumor cells an agent which inhibits cyclin G1 protein in an amount effective to inhibit cyclin G1 protein in tumor cells of the host. The agent may be an antisense polynucleotide which is complementary to at least a portion of a polynucleotide encoding cyclin G1 protein, or an antibody or fragment or derivative thereof which recognizes cyclin G1 protein. Also contemplated within the scope of the present invention are (i) the immortalization of cell lines by transducing cells with a polynucleotide encoding cyclin G1 protein; (ii) increasing the receptiveness of cells to retroviral infection by transducing cells with a polynucleotide encoding cyclin G1 protein; and (iii) the detection of cancer by detecting cyclin G1 protein or a polynucleotide encoding cyclin G1 protein in cells.
    Type: Grant
    Filed: October 26, 2006
    Date of Patent: October 20, 2009
    Assignee: University of Southern California
    Inventors: Erlinda M. Gordon, Frederick L. Hall, W. French Anderson
  • Patent number: 7604850
    Abstract: An electro-optical device including a biaxial liquid crystal having a primary and secondary director is provided. A change in orientation of at least one of the directors due to an applied electric field produces a change in the optical state of the device. Response times are increased dramatically over uniaxial nematic based liquid crystal devices, offering improved performance and efficiency.
    Type: Grant
    Filed: August 23, 2006
    Date of Patent: October 20, 2009
    Assignee: Kent State University
    Inventor: Satyendra Kumar
  • Patent number: 7606549
    Abstract: A disclosed method tunes a signal from a channelized spectrum having a predetermined channel spacing. A signal of interest having a predetermined maximum bandwidth is mixed with a local oscillator signal, which has a frequency that is an integer multiple of the channel spacing or one-half of a channel spacing displaced from an integer multiple of the channel spacing. The local oscillator signal is selected to frequency translate the signal of interest to within a near-baseband passband whose lower edge is spaced from DC by at least about the maximum bandwidth of the signal of interest. Problems associated with 1/f noise, DC offsets, and self-mixing products are avoided or substantially diminished. Other methods and systems are also disclosed.
    Type: Grant
    Filed: August 23, 2006
    Date of Patent: October 20, 2009
    Assignee: University of Washington
    Inventor: Edwin A. Suominen
  • Patent number: 7605132
    Abstract: Peptide factors isolated from skin following exposure to chemical or thermal injury and treatment with iodine preparations are capable of reducing or ameliorating the extent of injury when administered to other animals. Specific peptides, including fragments of histone H2A and fibrinopeptide A, and preferred derivatives of these peptides are disclosed. Pharmaceutical compositions and methods of using these peptides are also disclosed. The extracts, peptides and pharmaceutical compositions according to the invention are useful for the prevention and treatment of inflammatory conditions and exposure to noxious stimuli.
    Type: Grant
    Filed: May 18, 2007
    Date of Patent: October 20, 2009
    Assignee: Yissum Research Development Company of the Hebrew University of Jerusalem
    Inventor: Uri Wormser
  • Patent number: 7605984
    Abstract: A lens device with an adjustable focal length is provided. The lens device includes a non-conductive liquid droplet, which is surrounded by air or immiscible liquids. The non-conductive liquid droplet is placed on a bottom plate. The bottom plate includes a set of first electrodes. The set of first electrodes is disposed in such a way that the set of first electrodes are capable of being selectively biased to respectively create a first voltage potential difference between the liquid droplet and each of the set of first electrodes. With the first voltage potential differences, a dielectric force is induced, and the profile of the non-conductive liquid droplet is adjustable. Thus, the focal length of the lens is adjustable.
    Type: Grant
    Filed: September 20, 2006
    Date of Patent: October 20, 2009
    Assignee: National Tsing Hua University
    Inventors: Jer-Liang Andrew Yeh, Chih-Cheng Cheng, Chia-Ming Chang
  • Patent number: 7604807
    Abstract: Compositions and methods for the reversible preservation of biological samples are provided. The compositions include natural polymers such as pullulan or acacia gum, including derivations and modifications thereof, which are usefull as a reversible preservation solution. A method is provided for using pullulan or Acacia Gum to isolate and reversibly preserve a biological specimen in a dormant state at room temperature for an extended period with minimal damage to the specimen. The compositions and methods disclosed may also be used to create reversibly preserved biological specimens and biological receptors for use in biosensors.
    Type: Grant
    Filed: January 27, 2006
    Date of Patent: October 20, 2009
    Assignee: Auburn University
    Inventors: Vitaly J. Vodyanoy, James M. Barbaree, Bryan A. Chin, William Charles Neely, Suram T. Pathirana, Timothy D. Braden
  • Patent number: 7605150
    Abstract: Administering an effective dose of a tTGase inhibitor to a Celiac or dermatitis herpetiformis patient reduces the toxic effects of toxic gluten oligopeptides, thereby attenuating or eliminating the damaging effects of gluten.
    Type: Grant
    Filed: May 14, 2003
    Date of Patent: October 20, 2009
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Chaitan Khosla, Felix Hausch
  • Patent number: 7603883
    Abstract: An apparatus and method is disclosed for drawing continuous metallic wire having a first diameter to a metallic fiber having a reduced second diameter. A feed mechanism moves the wire at a first linear velocity. A laser beam heats a region of the wire to an elevated temperature. A draw mechanism draws the heated wire at a second and greater linear velocity for providing a drawn metallic fiber having the reduced second diameter.
    Type: Grant
    Filed: June 25, 2007
    Date of Patent: October 20, 2009
    Assignee: University of Central Florida
    Inventors: Nathaniel R. Quick, Aravinda Kar, Yonggang Li, Raymond R. McNeice
  • Patent number: 7604661
    Abstract: An valve prosthesis, such as an artificial venous valve, having a support frame and leaf structure comprising one or more leaflets in which the outer edge of each leaflet engages the inner circumference of the bodily passageway along a serpentine path urged against the passageway by an expandable frame, while the inner edges move in response to fluid to restrict retrograde flow. Optionally, one or more elements can extend from the support frame/leaf structure to provide centering support and/or protection from the leaflet adhering to the vessel wall. In one embodiment, the centering support structure comprises a second or third expandable frames attached to and extending from the proximal and/or distal ends of main valve structure and support frame. In another embodiment, one or more support elements extend outward from the valve support frame to engage the vessel wall to provide greater longitudinal stability.
    Type: Grant
    Filed: October 31, 2007
    Date of Patent: October 20, 2009
    Assignees: Cook Incorporated, William Cook Europe ApS, MED Institute, Oregon Health Sciences University
    Inventors: Dusan Pavcnik, Thomas A. Osborne, Brian C. Case, Jacob A. Flagle, Michael L. Garrison, Ram H. Paul, Jr., Andrew K. Hoffa, Raymond B. Leonard, II, Darin G. Schaeffer, Richard B. Sisken
  • Patent number: 7606542
    Abstract: A disclosed method tunes a signal from a channelized spectrum having a predetermined channel spacing. A signal of interest having a predetermined maximum bandwidth is mixed with a local oscillator signal, which has a frequency that is an integer multiple of the channel spacing or one-half of a channel spacing displaced from an integer multiple of the channel spacing. The local oscillator signal is selected to frequency translate the signal of interest to within a near-baseband passband whose lower edge is spaced from DC by at least about the maximum bandwidth of the signal of interest. Problems associated with 1/f noise, DC offsets, and self-mixing products are avoided or substantially diminished. Other methods and systems are also disclosed.
    Type: Grant
    Filed: June 15, 2005
    Date of Patent: October 20, 2009
    Assignee: University of Washington
    Inventor: Edwin A. Suominen
  • Patent number: 7605371
    Abstract: The mode-locking frequencies of two femtosecond laser light sources are controlled so that they are stabilized at high degree and the difference between the mode-locking frequencies is constant. The output of the laser light sources are used as a pumping light for generating terahertz pulses and a probe pulse light for terahertz detection. Since the time delay timings of the terahertz pulses and the probe pulse light the pulse periods of which are slightly different from each other shift from each other and the difference increases. Therefore, the temporally expanded terahertz pulses are measured by high-speed sampling without using any mechanical stage for time delay scanning. The terahertz electric field time waveform measured by high-speed sampling with the measurement time window of the pulse period is subjected to time-scale conversion and Fourier transform.
    Type: Grant
    Filed: August 30, 2005
    Date of Patent: October 20, 2009
    Assignee: Osaka University
    Inventors: Takeshi Yasui, Tsutomu Araki, Eisuke Saneyoshi